A high serum chloride concentration has been associated with the development of acute kidney injury in critically ill patients. However, the association between hyperchloremia and acute kidney injury (AKI) in patients admitted with ST-segment elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention (PCI) is unknown. A retrospective analysis of consecutive patients admitted with the diagnosis of STEMI and treated with PCI was performed. Subjects were classified as having hyper-or normochloremia based upon their admission serum chloride level. Multivariable logistic regression analyses were employed for the primary and secondary outcomes. The primary analysis evaluated whether high serum chloride on admission was associated with the development of AKI after adjusting for age, diabetes mellitus, admission systolic blood pressure, contrast volume used during angiography, Killip class, and need for vasopressor therapy or intraaortic balloon pump. The secondary analyses evaluated whether high serum chloride was associated with sustained ventricular tachycardia or fibrillation. Of 291 patients (26.1% female, mean age of 59.9 ± 12.6 years, and mean body mass index of 29.3 ± 6.1 kg/m 2 ), 25 (8.6%) developed AKI. High serum chloride on admission did not contribute significantly to the development of AKI (odds ratio, 95%; confidence interval, 0.90 to 1.24) . In addition, serum chloride on admission was not significantly associated with sustained ventricular tachycardia or fibrillation after adjusting for demographic and clinical covariates. In conclusion, our study demonstrated no association between baseline serum hyperchloremia and an increased risk of AKI in patients admitted with STEMI treated with PCI. C oronary angiography is the third leading cause of acute kidney injury (AKI) among hospitalized patients (1, 2) . Several risk factors for the development of radiocontrast-induced kidney injury have been identifi ed, including diabetes mellitus, chronic kidney disease, and heart failure (3) (4) (5) . Since AKI after angiography has been associated with a variety of adverse clinical outcomes, such as increased mortality, cardiovascular events, and prolonged hospitalization, several lines of investigation have focused on fi nding risk factors to predict its occurrence (6, 7) . Particularly, the relation between serum chloride concentration and the development of AKI has been gaining increasing attention. Among critically ill patients, the presence of a high chloride concentration prior to intensive care unit (ICU) admission has been associated with AKI.
Furthermore, a positive correlation between chloride levels and severity of AKI has also been described (8) . Recent investigations have shown that baseline hyperchloremia >110 mEq/L is associated with higher hospital mortality in critically ill septic patients (9) . Other recently published articles have revealed that the administration of chloride-enriched fl uids is associated with renal vasoconstriction and the subsequent decline of glomerular fi ltration rate (10, 11) . Consequently, strategies of fl uid resuscitation using chloride-restrictive solutions have been studied, demonstrating a lower incidence of AKI compared with chloride-liberal fl uid strategies (12) . Despite the aforementioned data, many gaps in our understanding of the relation between serum chloride levels and consequent AKI still remain. Specifically, whether high chloride concentration is a risk factor for the development of AKI in patients undergoing coronary angiography is currently unknown. Th is study addressed this question by analyzing data from a consecutive series of patients who underwent emergent cardiac catheterization due to ST-segment elevation myocardial infarction (STEMI) at our institution.
METHODS
We conducted a single-center retrospective study to assess the association between serum hyperchloremia at hospital admission and AKI in patients admitted with STEMI treated with emergent percutaneous coronary intervention (PCI). After approval by the institutional review board of the Creighton University School of Medicine, we collected data from patients admitted with STEMI who underwent emergent PCI from January 2003 to June 2010. Patients whose admission serum sodium was outside the physiological range, <135 and >145 mEq/L, were excluded. Hyperchloremia was defi ned as a serum chloride Serum hyperchloremia as a risk factor for acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention Nachiket Patel, MD, Sarah M. Baker, BSN, RN, Ryan W. Walters, MS, Ajay Kaja, MBBS, Vimalkumar Kandasamy, MBBS, Ahmed Abuzaid, MBChB, and Ariel M. Modrykamien, MD concentration >75% of the serum sodium concentration on the electrolyte panel obtained at the time of admission. Normochloremia was defi ned as a serum chloride concentration ≤75% of the serum sodium concentration (13) . Electrolyte measurements were performed using the Dimension Vista® 500 (Siemens, Newark, DE). Demographic, clinical, procedural, and outcome data were collected. Importantly, patients with end-stage renal disease undergoing intermittent hemodialysis or peritoneal dialysis, as well as pregnant women, were excluded from this study.
Th e primary outcome of interest was the development of AKI during the hospitalization, within 7 days after PCI. AKI was defi ned based on changes in creatinine concentration, according to criteria of the Acute Kidney Injury Network (14) . Th is classifi cation and staging system of AKI states that the elevation of baseline creatinine by 1.5 to 1.9 times, or an absolute increase of 0.3 mg/dL from the baseline (both within 48 hours of a known baseline), constitute the fi rst stage of AKI. Th e secondary endpoint was the development of either sustained ventricular tachycardia or ventricular fi brillation during the hospitalization. Sustained ventricular tachycardia was defi ned as lasting >30 seconds or requiring termination due to hemodynamic instability in <30 seconds (15) .
Continuous demographic and clinical variables are presented as mean ± standard deviation, whereas categorical variables are presented as frequency and percentage. Diff erences in these variables between patients who developed AKI and patients who did not were evaluated using independent-samples t tests for continuous variables and Pearson's χ 2 or Fisher's exact tests for categorical variables.
Multivariable logistic regression analyses were employed for the primary and secondary analyses. Th e primary analysis evaluated whether serum chloride on admission was associated with the development of AKI in patients admitted with STEMI after adjusting for age, diabetes mellitus, contrast volume (iopamidol 755 mg/mL, Bracco Diagnostics, NJ) administered, Killip class, use of pressor medications or intraaortic balloon pump, whether the patient suff ered cardiogenic shock during hospitalization, corrected anion gap, as well as systolic blood pressure, glomerular fi ltration rate, and systolic blood pressure on admission. Two secondary analyses evaluated whether serum chloride on admission was associated with sustained ventricular tachycardia or ventricular fi brillation after adjusting for the same demographic and clinical covariates listed above.
Th e accuracy of the logistic regression models was assessed by Hosmer and Lemeshow goodness of fi t as well as discriminative ability via C-statistic. Perfect discrimination yields a C-statistic of 1.0, whereas a C-statistic of 0.50 indicates that discrimination was no better than chance. For analysis, continuous variables were centered near their mean. All analyses were performed using SAS v. 9.3 (SAS Institute, Inc); P < .05 was considered statistically signifi cant for all analyses.
RESULTS
Of the 401 patients admitted with STEMI and treated with PCI between January 2003 and June 2010, 105 had abnormal serum sodium on admission (104 patients <135 mEq/L and 1 patient >145 mEq/L); these patients were excluded from analysis. Of the remaining 296 patients, 5 did not have complete data. Th us, analyses included 291 patients, with 26.1% female, a mean age of 59.9 ± 12.6 years, and a mean body mass index of 29.3 ± 6.1 kg/m 2 .
Descriptive statistics for demographic and clinical variables are presented in Table 1 . Of the 291 patients, 25 (8.6%) developed AKI and had signifi cantly greater corrected anion gap, as well as higher rates of intraaortic balloon pump use and cardiogenic shock, and were more likely to have higher Killip class compared with patients who did not develop AKI.
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Nonsignifi cant clinical covariates were included in the multivariable analysis due to theoretical considerations. Final model results from the multivariable logistic regression analysis for AKI are presented in Table 2 . Th e logistic model fi t the data well (χ 2 8 = 6.90, P = .55) with good discrimination (C = 0.81; 95% confi dence interval [CI] = 0.70 to 0.91). After adjustment, serum chloride on admission did not contribute signifi cantly to the development of AKI (odds ratio, 95%; CI = 0.90 to 1.24). In addition, serum chloride on admission was not signifi cantly associated with sustained ventricular tachycardia or fi brillation after adjusting for demographic and clinical covariates.
DISCUSSION
Th is study shows the following results: 1) hyperchloremia upon hospital admission is not associated with the development of AKI post-PCI, and 2) hyperchloremia is not associated with severe arrhythmias post-PCI, such as sustained ventricular tachycardia or ventricular fi brillation.
Several studies suggest adverse outcomes associated with the presence of serum hyperchloremia. Specifi cally, Zhang et al (8) retrospectively evaluated a consecutive series of patients admitted in a mixed ICU for the presence of hyperchloremia and its association with AKI. Interestingly, patients with higher chloride concentrations had a statistically signifi cant association with the development of AKI (chloride concentrations of 118.8 ± 8.1 vs 107.9 ± 5.4 mmol/L; P < 0.001). Notably, subgroup analyses aimed at studying particular ICU patients, such as those with trauma, abdominal surgery, and cardiovascular diseases, revealed similar results.
AKI in the context of hyperchloremia could be explained by several physiologic mechanisms. Wilcox et al (10) used an animal model to demonstrate the specifi c vasoconstrictive eff ect of chloride in renal vessels, with subsequent reduction of cortical perfusion and increase of infl ammatory mediators. Furthermore, Wu et al (16) specifi cally assessed the effect of chloride in the infl ammatory cascade. Strikingly, patients randomized to receive saline 0.9% had higher C-reactive protein levels and higher rates of systemic infl ammatory response syndrome compared with subjects treated with Ringer's solutions.
Based on the aforementioned data, recent investigations attempted to compare diff erent fl uid resuscitation strategies in critically ill patients. Particularly, Yunos et al (12) compared a chloride-restrictive vs a chloride-liberal fluid strategy in a before-and-after study. As expected, patients in the chloride-restrictive arm received less chloride (496 vs 694 mmol per patient) and had lower rates of AKI. Nevertheless, this study did not report serum chloride levels in each arm, limiting the interpretation of whether the presented outcome was directly associated with chloride concentrations.
Despite the studies demonstrating adverse renal outcomes associated with hyperchloremia and administration of chloride-liberal fl uids, our study did not show an association between hyperchloremia and the development of post-PCI AKI. However, these results seem to be in line with prior studies examining the eff ect of the type of fl uid administration on the development of AKI in patients undergoing coronary angiography, none of which demonstrated any relation between the concentration of chloride administered in the intravenous fl uid and the development of AKI. Specifi cally, Mueller et al (17) found that hydration with 0.9% saline before and after exposure to contrast media signifi cantly reduced the incidence of contrast-induced nephropathy compared with 0.45% saline with dextrose in patients undergoing coronary angiography. In addition, two prospective studies comparing 0.9% saline and isotonic bicarbonate in patients who received contrast media for coronary angiography found no diff erence in the development of contrast-induced nephropathy (18, 19) . Th e role of chloride in the development of AKI in patients undergoing coronary angiography and PCI remains to be clarifi ed.
We focused our study on patients with STEMI treated with PCI. Th is particular group has an increased incidence of AKI postprocedure, mostly due to contrast nephrotoxicity. As a matter of fact, the rate of kidney injury in this patient population ranges from 2% to 30%, being higher in individuals with baseline creatinine >2 mg/dL prior to the procedure (3, 20) . Previous studies revealed a higher incidence of AKI postangiography in specifi c populations, such as those with preexisting renal disease, diabetes, congestive heart failure, and those receiving large intraprocedural volumes of hyperosmolar contrast (21) (22) (23) (24) (25) . However, we were unable to fi nd these associations after adjustment for some of those variables. It is possible that our sample was not large enough to fi nd the aforementioned results. We attempted to assess whether the presence of hyperchloremia was associated with severe cardiac arrhythmias, namely sustained ventricular tachycardia or fi brillation. Studies in animal models and humans showed associations between electrolyte disturbances and cardiac arrhythmias. Th e cardiac implications of potassium, calcium, magnesium, and sodium alterations have been extensively described (26) (27) (28) (29) (30) (31) (32) . Nevertheless, no prior reports have focused on the eventual arrhythmogenic eff ects of abnormal chloride concentrations. Our study revealed no signifi cant diff erences in the incidence of ventricular arrhythmias associated with chloride levels.
Th e present study has many strengths. First, this is the fi rst report that aimed to assess the relationship between baseline chloride concentrations and kidney function post-PCI. Second, this is the fi rst study to address the impact of hyperchloremia in cardiac arrhythmias. Although we did not fi nd any association between serum chloride levels and arrhythmias, our study may be hypothesis generating for further research in this area. Th ird, variables included in our statistical analysis were obtained from prior validated models, which showed association between each of them and the development of contrast-induced nephropathy (33) .
Despite its strengths, our study also presents several limitations. First, being a retrospective study, it is likely that we incurred a selection bias. Th e lack of relevant information on nine patients aff ected the completeness of our dataset. Th erefore, it is possible that our results may have changed had these subjects been included. Second, the small number of patients could have led to underestimation of important diff erences in clinical outcomes, such as incidence of cardiac arrhythmias. Last, a number of relevant factors, such as hemoglobin A1c levels, ventricular ejection fraction, and use of prior nephrotoxic medications, were not included in our dataset. Th ese meaningful factors could have altered the incidence of AKI without our knowledge.
